Vlasroot: How can we help your company to be more successful?
Vlasroot is a group of informal investors who focus on SME’s with growth potential, a proven ‘track record’ and a strong management team. Companies that provide real solutions for real problems. We offer an experienced team with a considerable experience in both business and investing and know how to make companies grow. We help companies to raise the bar and reach targets. We believe in co-creation and offer our network and expertise to our portfolio companies.
What companies are we looking for?
We identify the potential winners by looking at the below 5 criteria, heavily weighted towards the team:
1. Team: Entrepreneurship / technical / commercial
2. Value proposition: Urgency of problem / quality of solution / defensibility
3. Business model: Product-market fit / scalability
4. Market attractiveness: Market size & growth / Competitive dynamics
5. Investment dynamics: Capital activity / Exit options
What can we do for your company?
The "central lab” anywhere 24/7
NBCL (Novel Biomarkers Catalyst Lab) was founded in 2012 and is located at our offices and laboratories at Kerkenbos in Nijmegen the Netherlands. NBCL has an experienced immunoassay development team and works on the development of new immunoassays on the NBCL platform.
NBCL has an assay development laboratory and can perform small scale immunoassay production. NBCL is dedicated to the development and commercialisation of immunoassays that are or become important diagnostic tools in clinical management.
RiboPro - your one-stop-shop for messenger RNA and long non-coding RNA
RiboPro is a knowledge-driven biotech start-up focussed on the R&D, production and sale of custom messenger RNA products to customers worldwide. Via our high-quality, high-potency RNA products, which are used as powerful research tools and therapeutics, we enable academic, biotech and pharma researchers to do better science, create more powerful medicines and develop vaccines faster than ever before. RiboPro was founded by Sander van Asbeck (CEO), Dr. Jürgen Dieker (CSO) and Dr. Roland Brock.